Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTIRY6K)

DTT Name	Cellular inhibitor of apoptosis 2 (BIRC3) DTT Info
Gene Name	BIRC3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AT-406	DMVJW0S	Squamous head and neck cell carcinom	2D60.0	Phase 3	[1]
------------------------------------------------------------------------------------

4 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID25980951-Compound-1	DMYPT2H	N. A.	N. A.	Patented	[2]
PMID25980951-Compound-27	DMXAH9F	N. A.	N. A.	Patented	[2]
PMID25980951-Compound-43	DMTJRCS	N. A.	N. A.	Patented	[2]
PMID25980951-Compound-44	DMS5896	N. A.	N. A.	Patented	[2]
------------------------------------------------------------------------------------

1 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AZD5582	DMPIHN6	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung c... Am J Cancer Res. 2014 Nov 19;4(6):943-51.
2	Small molecule inhibitor of apoptosis proteins antagonists: a patent review.Expert Opin Ther Pat. 2015 Jul;25(7):755-74.
3	Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582). J Med Chem. 2013 Dec 27;56(24):9897-919.